In patients with GSTM1 polymorphism, lymph node metastasis was associated with pN1 vs. pN2 (pN classification; p = 0.036), suggesting that this polymorphism may affect tumor stage. Here, GSTM1 is linked to metastatic malignant neoplasm in the lymph nodes.